G

Global Antibiotic R&D Partnership (GARDP)

76 employees

GARDP aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging

Basic info

Industry

research services

Sectors

global health
Biotechnology
gonorrhoea
serious bacterial infections
antibiotic access
antibiotic drug development
R&D partnerships
children’s antibiotics
sexually transmitted infections
sepsis and neonatal sepsis
Antibiotic resistance
public health
pandemic preparedness

Date founded

2016

FAQ